NEULAND LABORATORIES LTD. - 524558 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of Letter of Confirmation in lieu of Share Certificate(s) reported lost / misplaced31-05-2024
31-05-2024
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation about Schedule of Analyst / Institutional Investor Meetings on 03/06/202428-05-2024
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation about Schedule of Analyst / Institutional Investor Meetings on 31/05/202428-05-2024
NEULAND LABORATORIES LTD. - 524558 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the year ended March 31, 202424-05-2024
NEULAND LABORATORIES LTD. - 524558 - Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 201523-05-2024
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of the Earnings call conducted on May 14, 202417-05-2024
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed the link of the audio recording of the Earnings call for the quarter and year ended March 31, 2024, conducted on May 14, 202414-05-2024
Neuland Laboratories Results Earnings Call for Q4FY24
Conference Call with Neuland Laboratories Management and Analysts on Q4FY24 Performance and Outlook. Listen to the full earnings transcript.14-05-2024
Neuland Labs Shares Tumble Nearly 15% After Profit Declines 20% In Q4
The company reported a consolidate net profit of Rs 67.6 crore during the January-March quarter, compared with Rs 84.5 crore a year ago, beating Bloomberg estimated of Rs 24.4 crore.13-05-2024
NEULAND LABORATORIES LTD. - 524558 - Announcement under Regulation 30 (LODR)-Investor Presentation
Revised Investors Presentation on the Financial Results of the Company for the quarter and year ended March 31, 202412-05-2024